Venous thromboembolic and hemorrhagic events after meningioma surgery: A single-center retrospective cohort study of risk factors.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 27 07 2021
accepted: 04 08 2022
entrez: 16 8 2022
pubmed: 17 8 2022
medline: 19 8 2022
Statut: epublish

Résumé

Microsurgical resection of meningiomas in a majority of cases leads to a favorable outcome. Therefore, severe postoperative adverse events are less acceptable. The main purpose of this study was to investigate the incidence of symptomatic venous thromboembolism (VTE) and hemorrhagic complications in patients after operative treatment of intracranial meningiomas and to identify the risk factors in this patient subgroup. Of 106 patients undergoing elective craniotomy for meningioma overall incidence of symptomatic VTE was noted in 5.7% (six patients). For the risk-factor analysis older age (57.20 ± 11.60 vs. 71.00 ± 0.90 years, p < 0.001), higher body mass index (27.60 ± 4.80 vs. 33.16 ± 0.60 kg/m2, p < 0.001), WHO grade II (3.00% vs. 33.33%, p = 0.02), lower intraoperative blood loss (466.00 ± 383.70 vs. 216.70 ± 68.30 mL, p < 0.001), bedridden status and neurologic deficit (0.00% vs. 33.33%, p = 0.003 and 38.00% vs. 100.00%, p = 0.004) were associated with greater VTE risk. No risk factors for hemorrhagic complications were identified on univariate analysis. In conclusion, the incidence of VTE in meningioma patients is not negligible. Identified risk factors should be taken into account in the decision-making process for chemoprophylaxis when the risk of bleeding decreases.

Identifiants

pubmed: 35972947
doi: 10.1371/journal.pone.0273189
pii: PONE-D-21-24338
pmc: PMC9380925
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0273189

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Chest. 2012 Feb;141(2 Suppl):e227S-e277S
pubmed: 22315263
J Thromb Thrombolysis. 2010 May;29(4):489-96
pubmed: 19536458
Clin Neurol Neurosurg. 2014 Aug;123:150-4
pubmed: 24956544
Crit Care Med. 2010 Feb;38(2 Suppl):S3-9
pubmed: 20083911
Blood. 1995 Jun 1;85(11):3144-9
pubmed: 7756646
J Thromb Haemost. 2016 Jul;14(7):1480-3
pubmed: 27428935
World Neurosurg. 2016 Jul;91:58-65
pubmed: 27062920
Physiol Rev. 2013 Jan;93(1):359-404
pubmed: 23303913
J Clin Neurosci. 2019 Jan;59:218-223
pubmed: 30309806
Neurosurgery. 2017 Jan 01;80(1):73-81
pubmed: 27258769
Neurosurgery. 1991 Jun;28(6):859-63
pubmed: 2067609
Clin Appl Thromb Hemost. 2018 Sep;24(6):986-992
pubmed: 28877605
J Clin Invest. 1987 Dec;80(6):1527-34
pubmed: 2824564
J Neurooncol. 2009 May;93(1):151-6
pubmed: 19430892
J Neurosurg. 2011 Jan;114(1):40-6
pubmed: 20815694
Nat Rev Cardiol. 2015 Aug;12(8):464-74
pubmed: 26076949
J Neurooncol. 1992 Oct;14(2):119-25
pubmed: 1331348
J Neurosurg. 2011 Mar;114(3):697-704
pubmed: 20653395
Clin Neurol Neurosurg. 2016 May;144:1-6
pubmed: 26945875
Crit Rev Oncol Hematol. 2006 Nov;60(2):144-51
pubmed: 16860994
Thromb Res. 1980 Sep 15;19(6):799-805
pubmed: 7466748
World Neurosurg. 2019 Feb;122:e1505-e1510
pubmed: 30468929
PLoS One. 2013 Nov 14;8(11):e79170
pubmed: 24244441
Arch Intern Med. 2004 Nov 8;164(20):2260-5
pubmed: 15534164
J Neurooncol. 2014 Dec;120(3):567-73
pubmed: 25149164
Clin Neurol Neurosurg. 2014 Apr;119:116-20
pubmed: 24635939
Nat Rev Dis Primers. 2015 May 07;1:15006
pubmed: 27189130
J Neurooncol. 2010 Sep;99(3):307-14
pubmed: 20821343
Arch Intern Med. 2003 Jul 28;163(14):1711-7
pubmed: 12885687
J Neurooncol. 2018 Jun;138(2):401-406
pubmed: 29500662
World Neurosurg. 2016 Apr;88:320-326
pubmed: 26746334
Lancet. 2021 Jul 3;398(10294):64-77
pubmed: 33984268
Hypertension. 2001 Aug;38(2):274-9
pubmed: 11509489
Curr Opin Hematol. 2013 Sep;20(5):437-44
pubmed: 23817170
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Am J Med. 2006 Jan;119(1):60-8
pubmed: 16431186
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
J Neurooncol. 2017 Jan;131(1):59-67
pubmed: 27864707
Am J Med. 1990 Jun;88(6):601-6
pubmed: 2161185
Neurosurgery. 2005 Jun;56(6):1286-92; discussion 1292-4
pubmed: 15918945
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Semin Thromb Hemost. 2002 Dec;28(6):555-68
pubmed: 12536349

Auteurs

Nebojsa Lasica (N)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Djula Djilvesi (D)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Vladimir Papic (V)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Mladen Karan (M)

Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.

Bojan Jelaca (B)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Jagos Golubovic (J)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Filip Pajicic (F)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Milica Medic-Stojanoska (M)

Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Vojvodina, Novi Sad, Serbia.

Petar Vulekovic (P)

Clinic of Neurosurgery, Clinical Center of Vojvodina, Novi Sad, Serbia.
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Lukas Rasulic (L)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Neurosurgery, Clinical Center of Serbia, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH